Surgery has long been part of the orthopedic care continuum. When conservative care is no longer helpful, people were left with two choices: either remain in pain or have surgery. However, Mark Testa, Executive Vice President of Regenexx, joins this week's episode to discuss how orthobiologics - using a patient's own cells - can serve to fill the gap between conservative care and surgery and the benefit that it brings both employers and employees.